
FDA Watch: MeMed and NG Biotech Receive FDA Breakthrough Device Designations for Rapid Infection Tests
In both cases, the diagnostic tests report results back within 15 minutes

In both cases, the diagnostic tests report results back within 15 minutes

The Syn-One assay can diagnose multiple conditions without needing a lumbar puncture

FDA-approved tests like Intellisep and TriVerity demonstrate potential for early sepsis diagnosis

Join G2 Intelligence for this interactive discussion about whether clinical immunohistochemistry testing should be a stain or an assay, with our experts offering arguments for and against the proposed changes

Join us and our experts to learn how labs can reimagine infrastructure utilization through collaboration to improve health system finances and enrich their value proposition